MSB 4.66% $1.46 mesoblast limited

Who will win

  1. 2,524 Posts.
    lightbulb Created with Sketch. 142
    Mesoblast is a privately listed medical company that specialises in stem cell research. They have invented cutting edge technology that does not see the patient pop a pill. Its technologies are saving lives, but are struggling to get FDA approval due to the experimental nature of the drugs design. How will the American market (patient / medical consumer) and the FDA cope with a medicine that doesn't come in a pill form. Pills are socially acceptable in medicine but stem cells are questionable. While your thinking about that debate, another one rages in the background too....making money from medicine. Investors can make serious money from the misfortune of illness, at the same time lives are saved and lives are lost via FDA approving drugs that are possibly unsafe. Here is a investor video so you can make your mind up about a chart and a company that is saving lives, but struggling to get approval.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.46
Change
0.065(4.66%)
Mkt cap ! $1.667B
Open High Low Value Volume
$1.41 $1.50 $1.40 $5.699M 3.943M

Buyers (Bids)

No. Vol. Price($)
5 122380 $1.46
 

Sellers (Offers)

Price($) Vol. No.
$1.46 11015 2
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.